WO2003102173A8 - Protein or peptide (mimpd), nucleic acid that codes therefor, and uses of these substances - Google Patents

Protein or peptide (mimpd), nucleic acid that codes therefor, and uses of these substances

Info

Publication number
WO2003102173A8
WO2003102173A8 PCT/DE2003/001824 DE0301824W WO03102173A8 WO 2003102173 A8 WO2003102173 A8 WO 2003102173A8 DE 0301824 W DE0301824 W DE 0301824W WO 03102173 A8 WO03102173 A8 WO 03102173A8
Authority
WO
WIPO (PCT)
Prior art keywords
mimpd
peptide
protein
substances
nucleic acid
Prior art date
Application number
PCT/DE2003/001824
Other languages
German (de)
French (fr)
Other versions
WO2003102173A2 (en
Inventor
Edgar Dahl
Katrin Gottlob
Bernd Hinzmann
Karin Blechschmidt
Anke Stein
Christian Pilarsky
Thomas Specht
Andre Rosenthal
Rosemarie Lichtner
Georg Beckmann
Irina Klamann
Armin Schmidt
Original Assignee
Metagen Pharmaceuticals Gmbh
Edgar Dahl
Katrin Gottlob
Bernd Hinzmann
Karin Blechschmidt
Anke Stein
Christian Pilarsky
Thomas Specht
Andre Rosenthal
Rosemarie Lichtner
Georg Beckmann
Irina Klamann
Armin Schmidt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Metagen Pharmaceuticals Gmbh, Edgar Dahl, Katrin Gottlob, Bernd Hinzmann, Karin Blechschmidt, Anke Stein, Christian Pilarsky, Thomas Specht, Andre Rosenthal, Rosemarie Lichtner, Georg Beckmann, Irina Klamann, Armin Schmidt filed Critical Metagen Pharmaceuticals Gmbh
Priority to AU2003243913A priority Critical patent/AU2003243913A1/en
Publication of WO2003102173A2 publication Critical patent/WO2003102173A2/en
Publication of WO2003102173A8 publication Critical patent/WO2003102173A8/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

.
PCT/DE2003/001824 2002-05-31 2003-05-30 Protein or peptide (mimpd), nucleic acid that codes therefor, and uses of these substances WO2003102173A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003243913A AU2003243913A1 (en) 2002-05-31 2003-05-30 Protein or peptide (mimpd), nucleic acid that codes therefor, and uses of these substances

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2002125180 DE10225180A1 (en) 2002-05-31 2002-05-31 Protein or peptide (MIMPD), nucleic acid coding therefor and uses of these substances
DE10225180.0 2002-05-31

Publications (2)

Publication Number Publication Date
WO2003102173A2 WO2003102173A2 (en) 2003-12-11
WO2003102173A8 true WO2003102173A8 (en) 2004-08-05

Family

ID=29594304

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE2003/001824 WO2003102173A2 (en) 2002-05-31 2003-05-30 Protein or peptide (mimpd), nucleic acid that codes therefor, and uses of these substances

Country Status (3)

Country Link
AU (1) AU2003243913A1 (en)
DE (1) DE10225180A1 (en)
WO (1) WO2003102173A2 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6225054B1 (en) * 1996-01-11 2001-05-01 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer

Also Published As

Publication number Publication date
DE10225180A1 (en) 2004-02-12
AU2003243913A1 (en) 2003-12-19
WO2003102173A2 (en) 2003-12-11

Similar Documents

Publication Publication Date Title
WO2005047459A3 (en) Sars nucleic acids, proteins, antibodies, and uses thereof
AU2002236300A1 (en) Novel protein, gene encoding the same and method of using the same
AU2002214542A1 (en) Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
AU2002258630A1 (en) Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
WO2003102173A8 (en) Protein or peptide (mimpd), nucleic acid that codes therefor, and uses of these substances
AU2001288363A1 (en) Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
AU2002306860A1 (en) Isolated human nadph oxidase, nucleic acid molecules encoding said proteins, and uses thereof
AU2002256019A1 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
AU2002258617A1 (en) Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
AU2002303137A1 (en) Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
AU2002257075A1 (en) Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
AU2002229060A1 (en) Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
AU2002250346A1 (en) Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
AU2002356494A1 (en) Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
WO2003040393A3 (en) Nucleic acids encoding proteases
AU2002240295A1 (en) Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
AU2002257016A1 (en) Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
AU2002305909A1 (en) Isolated human transporter protein, nucleic acid molecules encoding human transporter protein, and uses thereof
AU2003222241A1 (en) Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
AU2003209105A1 (en) Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
AU2002245514A1 (en) Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
AU2003231478A1 (en) Novel protein, its dna and use thereof
AU2002303180A1 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
AU2002311750A1 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
AU2002338447A1 (en) Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
D17 Declaration under article 17(2)a
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase in:

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP